Roche Targets Over 40% Diabetes Market Share Through R&D Investments

Roche Diagnostics is concentrating its $150 mil. diabetes R&D budget on integrated management systems such as continuous strips, lancing strips and measuring needles for blood glucose testing

More from Archive

More from Medtech Insight